Get started

Community ideas

"LEMONTREE Approaching Key Resistance: Breakout or Reversal?" "🛎 LEMONTREE is trading near a major resistance zone of ₹159-160. This level has acted as a barrier in the past, but the recent uptrend and strong volumes signal potential bullish momentum. 📈 Technical Highlights: Resistance: ₹160 (critical breakout level). Targets: ₹170 | ₹180 | 200 (on successful breakout). Stop-Loss: ₹145-₹150 (below recent consolidation). 🔍 Watchlist Points: A strong breakout above ₹160 with increased volume could propel the stock toward ₹170-₹200. Failure to break ₹160 might result in a retest of ₹145-152. 💡 Strategy: Aggressive traders can enter on a breakout above ₹160. Conservative traders may wait for a retest of the breakout level before entering. #SwingTrading #LEMONTREE #BreakoutTrade #StockMarket #TechnicalAnalysis
NSE:LEMONTREELong
by TraderChhabra
"Kalyan Jewellers (KALYANKJIL): Fibonacci Targets After BreakoutKalyan Jewellers (KALYANKJIL) is at a critical juncture after confirming a bullish inverted head & shoulders breakout. The stock is currently retesting its neckline around ₹773.45, presenting a compelling risk-reward setup. 1.Pattern Formation: ->The inverted head & shoulders pattern is intact, signaling bullish momentum. ->Neckline at ₹773.45 acts as the key breakout level. 2.Fibonacci Targets: ->1.618 (₹812): Immediate target. ->2.618 (₹871) and 3.618 (₹929): Mid-term targets. ->4.236 (₹965): Extended target for strong bullish momentum. 3.Support Levels: ->₹724 (0.786 retracement): Strong support from Fibonacci and previous lows. ->Trendline Support: Indicates continued uptrend. 4.Risk-Reward Setup: ->Buy Zone: Sustained move above ₹773.45 with volume. ->Stop-Loss: ₹718.60 to minimize downside risk. ->Targets: ₹812, ₹871, ₹929, and ₹965. Final Thoughts: The stock is consolidating near its neckline, providing an opportunity for bullish traders to enter with defined risk. The Fibonacci levels align perfectly with the pattern targets, adding further confidence in the upside potential. Are you tracking this breakout? Let us know your targets and stop-loss levels in the comments below!
NSE:KALYANKJILLong
by TraderChhabra
Stock Analysis: #PARAS – Early Potential ReversalHello, Traders! 👋 Let’s talk about #PARAS, a defence sector stock that is showing strong signs of a potential upmove. Here's the breakdown: 📈 Technical Overview: 🔹 The stock has posted its highest quarterly volume for consecutive days, indicating strong accumulation. 🔹 It is trading near a multi-week breakout level on the weekly chart and is well above the last two weeks' highs. 🔹 Momentum in the defence sector aligns well with the stock's setup, enhancing its potential. 💡 My View: My ILTF indicator signaled an entry earlier, but broader market conditions weren’t favorable then, leading to an exit signal later. Now, it looks like #PARAS might turn positive again. Tracking closely for confirmation. ⚠️ Disclaimer: 🔹 I am not a SEBI-registered advisor. 🔹 This analysis reflects my personal views and is not a recommendation to buy or sell. 🔹 Shared for learning purposes only—please do your own research or consult a professional. Are you watching the defence sector momentum? Let’s discuss #PARAS! 🚀 #TradingView #StockAnalysis #DefenceStocks #MomentumTrading #PARAS
NSE:PARAS
by Inwardlocus
Morepen Lab Near Key Support – Big Move Ahead?Morepen Laboratories (NSE: MOREPENLAB) - A Critical Technical Setup In-Depth Chart Analysis 1. Descending Trendline Resistance: • The stock is moving within a descending triangle pattern, with a clear downward trendline acting as resistance since the peak around ₹120. • Currently, the stock is approaching this trendline near ₹80. A breakout above this level, supported by strong volume, could trigger bullish momentum. 2. Key Moving Averages: • 200-Day EMA (Exponential Moving Average): The 200-day EMA is positioned at ₹69.66, which serves as a critical long-term support. The stock has tested this level multiple times, indicating its importance. • The price is hovering slightly above the EMA, suggesting the stock is at a decisive point for trend confirmation. 3. Support Levels: • ₹69.66: Immediate support lies here, aligning with the 200-day EMA. If this level holds, the stock could see a bounce toward higher resistance levels. • ₹65.00 and ₹55.00: If the stock fails to hold ₹69.66, it could slide to ₹65.00, a psychological support, and then to ₹55.00, which marks a previous consolidation zone. 4. Resistance Levels: • ₹80.00: The descending trendline converges with this resistance. A breakout above ₹80.00 could open the path to ₹95.00. • ₹95.00: A crucial horizontal resistance zone. Beyond this, ₹115.00 could be the next major target. 5. Volume Profile: • Recent volume spikes near support levels suggest accumulation by long-term investors. • Watch for increasing volume during any breakout above ₹80.00, which would confirm strong buying interest. 6. Bollinger Bands: • The price is trading near the lower Bollinger Band, indicating oversold conditions. • A rebound toward the middle or upper band could align with a breakout above the ₹80.00 resistance. 7. RSI (Relative Strength Index): • The RSI is nearing the oversold zone, typically a precursor to a potential reversal. 8. Symmetrical Triangle Formation: • The stock’s current price action within a triangle pattern indicates consolidation. A breakout above the upper trendline or a breakdown below the lower support will dictate the next directional move. Possible Scenarios: Bullish Scenario: • A breakout above ₹80.00 with high volume can propel the stock to test ₹95.00 in the short term. • Sustaining above ₹95.00 could lead to a rally toward ₹115.00, marking a significant reversal of the bearish trend. Bearish Scenario: • A breakdown below ₹69.66 would indicate the continuation of the descending triangle, leading to lower levels like ₹65.00 and ₹55.00. • Increased selling pressure or market weakness could exacerbate the downside. About Morepen Laboratories Company Overview: Morepen Laboratories is a pharmaceutical and healthcare company specializing in Active Pharmaceutical Ingredients (APIs), formulations, and diagnostics. With a strong domestic presence and growing exports, the company’s key products include Loratadine (an anti-allergic API) and well-known OTC brands like Burnol and Dr. Morepen. Financial Highlights: • Revenue: The company has demonstrated consistent revenue growth, driven by exports and rising healthcare demand in India. • Margins: Operating margins are moderate, with scope for improvement as exports scale up. • Debt Levels: A low debt-to-equity ratio reflects strong financial stability. • Cash Flow: Positive operating cash flow highlights effective financial management. Growth Drivers: 1. Increasing demand for APIs globally, especially in regulated markets. 2. Expansion into diagnostics and OTC segments, with a focus on high-margin products. 3. Government incentives under the “Make in India” initiative for the pharmaceutical sector. 4. Investment in R&D to create niche formulations and increase market penetration. Conclusion: The stock is at a pivotal technical and fundamental point. A decisive breakout above ₹80.00 could signal the start of a bullish trend, while a breakdown below ₹69.66 might lead to further downside. Disclaimer: This analysis is for educational purposes only and does not constitute financial advice. Please conduct your own research and consult a certified financial advisor before making investment decisions.
NSE:MOREPENLAB
by Veersoni108
XAUUSD MULTI TIME FRAME ANALYSISHello traders , here is the full multi time frame analysis for this pair, let me know in the comment section below if you have any questions , the entry will be taken only if all rules of the strategies will be satisfied. wait for more price action to develop before taking any position. I suggest you keep this pair on your watchlist and see if the rules of your strategy are satisfied. 🧠💡 Share your unique analysis, thoughts, and ideas in the comments section below. I'm excited to hear your perspective on this pair . 💭🔍 Don't hesitate to comment if you have any questions or queries regarding this analysis.
OANDA:XAUUSDLong
by okako_trading
MIDCAP Index towards 52K?Midcap Index: Price was rejecting from 1.618% fib extension.. looks to have completed 3 waves and is now in corrective 4th. Probable path for the future price action is depicted here.. this is illustrative only as I believe that this can be a WXY correction.. or even wxyxz.. but we will come to know once the price unfolds.. I am not a SEBI registered Analyst. Views are personal and for educational purpose only. Please consult your Financial Advisor for any investment decisions. Please consider my views only to get a different perspective (FOR or AGAINST your views). Please don't trade FNO based on my views.
NSE:CNXMIDCAPShort
by Murthy_Santhosh